113 related articles for article (PubMed ID: 7600910)
1. A method of determining the in vivo drug release rate constant of sustained-release preparation.
Sun H; Chow MS
Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910
[TBL] [Abstract][Full Text] [Related]
2. The time to reach steady state after the administration of intravenous bolus, constant infusion, and oral immediate-release and sustained-release preparations.
Chow MS; Sun H
Pharmacotherapy; 1990; 10(6):400-5. PubMed ID: 2287561
[TBL] [Abstract][Full Text] [Related]
3. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
Konsil J; Dechasathian S; Mason DH; Stevens RE
J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
[TBL] [Abstract][Full Text] [Related]
4. Drug absorption: a practical method to estimate the absorption rate constant.
Lambert C; du Souich P
Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):217-29. PubMed ID: 7335952
[TBL] [Abstract][Full Text] [Related]
5. Predicting plasma procainamide concentrations resulting from a sustained-release preparation.
DiPersio DM; Chow MS
Clin Pharm; 1985; 4(2):186-91. PubMed ID: 3987218
[TBL] [Abstract][Full Text] [Related]
6. Unique approach for calculation of absorption rate constant.
Pidgeon C; Pitlick WH
Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):467-75. PubMed ID: 928947
[TBL] [Abstract][Full Text] [Related]
7. [Computer simulation of blood level profiles. Drug liberation from two sustained-release preparations and computer simulation of single- and multiple-dose pharmacokinetics].
Koch HP
Pharmazie; 1992 Jul; 47(7):547-52. PubMed ID: 1518902
[TBL] [Abstract][Full Text] [Related]
8. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
Sobol E; Bialer M
Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
[TBL] [Abstract][Full Text] [Related]
9. Improved rearrangement of the integrated Michaelis-Menten equation for calculating in vivo kinetics of transport and metabolism.
Russell RW; Drane JW
J Dairy Sci; 1992 Dec; 75(12):3455-64. PubMed ID: 1474212
[TBL] [Abstract][Full Text] [Related]
10. Application of non parametric methods to pharmacokinetic models of the Michaelis-Menten type.
Pereira LM; Maya MT; Morais JA
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():497-500. PubMed ID: 1820929
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
13. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
Lennernäs H
Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809
[TBL] [Abstract][Full Text] [Related]
14. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ethanol drinking--absorption kinetics and first-pass effect.
Fujimiya T; Fukui Y; Komura S
Nihon Hoigaku Zasshi; 1995 Apr; 49(2):92-103. PubMed ID: 7783393
[TBL] [Abstract][Full Text] [Related]
16. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
[TBL] [Abstract][Full Text] [Related]
17. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
[TBL] [Abstract][Full Text] [Related]
18. A nomogram for prediction of absorption rate coefficient.
Li YH; Zhao X; Ji Q; Xu JG; Sun RY
Chin Med J (Engl); 2004 May; 117(5):689-94. PubMed ID: 15161535
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the error in the Loo-Riegelman method for estimating the rate of drug absorption. Some suggestions for a practical sampling schedule.
Zeng YL; Akkermans AA; Breimer DD
Arzneimittelforschung; 1983; 33(5):757-60. PubMed ID: 6688184
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics and relative bioavailability for different preparations of nitrofurantoin.
Maier-Lenz H; Ringwelski L; Windorfer A
Arzneimittelforschung; 1979; 29(12):1898-901. PubMed ID: 583541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
